Zastosowanie szczepionek w prewencji HPV-zależnych raków głowy i szyi oraz brodawczaków krtani
Journal Title: Otolaryngologia Polska - Year 2014, Vol 68, Issue 4
Abstract
Recent data demonstrate that human papilloma virus (HPV) plays a role in pathologies other than ano-genital cancers, specifically head and neck malignancies, and non-cancerous conditions such as recurrent respiratory papillomatosis (RRP). High-risk HPV16 and 18, and low risk HPV6 and 11 play the main role in HPV-related pathologies. As more and more information about the role of HPV infection in non-cervical diseases is amassed, additional questions about whether prophylactic HPV vaccines will effectively prevent these conditions are raised. HPV vaccination programs for the cervical pathology are being implemented worldwide. In the United States, the US Food and Drug Administration (FDA) approved the qua drivalent HPV vaccine for girls in 2006 and for boys in 2011. These vaccination programs were aimed at the genital, HPV-related lesions, and there was not much recognition at that time of how HPV vaccination programs might affect oral HPV infection, which is a risk factor for the development of HPV-related head and neck cancers. Vaccination has proved to be a successful policy, and an extant recommendation is aimed at preventing HPV and associated cervical and other anogenital cancers with the routine use of HPV vaccines for males and females. However, HPV vaccines are presently not recommended for preventing oropharyngeal cancer (OPC), although they have been shown to be highly effective against the HPV strains that are most commonly found in the oropharynx. This review is aimed at presenting the evidence-based knowledge concerning HPV vaccination and highlighting the trials and strategies for vaccine administration in HPV-dependent head and neck pathologies.
Authors and Affiliations
Małgorzata Wierzbicka, Agata Józefiak, Joanna Jackowska, Jarosław Szydłowski, Anna Goździcka-Józefiak
Rola czynników psychologicznych w patogenezie zaburzeń głosu spowodowanych guzkami głosowymi
Introduction. Hoarseness is most frequent complaint notifi ed by ill in phoniatric outpatient clinics. Looking of causes notifi ed of disturbances of voice often we ascertain in larynx existence of vocal nodules. Changes...
Metaloproteinazy macierzy zewnątrzkomórkowej MMP1, MMP2, MMP9 oraz ich inhibitory tkankowe TIMP1, TIMP2, TIMP3 w rakach głowy i szyi: badanie immunohistochemiczne
Wstęp: Metaloproteinazy macierzy zewnątrzkomórkowej (MMP) należą do rodziny enzymów proteolitycznych. Z uwagi na swą zdolność rozkładania składników macierzy pozakomórkowej biorą udział w naciekaniu oraz tworzeniu przerz...
Challenges of modern medicine - geriatric otolaryngology or the advantages of cooperation between an otolaryngologist and a geriatrician
Advanced age is often burdened with many deficits that are a consequence of the aging process, unfavorable lifestyle and multi-morbidity. They contribute to increased morbidity and disability of the older people. Laryngo...
Problematyka monitorowania chorych leczonych z powodu nowotworów głowy i szyi
Radiotherapy induced xerostomia: Mechanisms, diagnostics, prevention and treatment – Evidence based up to 2013
Definition and prevalence of xerostomia were shortly presented. Radiosensitivity of the salivary glands, mechanism, diagnostics, and possible prediction methods of the intensity of xerostomia in the pre-radiotherapy peri...